News & Perspective

Jun 28, 2012

Jun 28, 2012

FDA bill includes incentive for new antibiotics

(CIDRAP News) – Some provisions included in a measure that passed Congress this week represent a good first step to spur development of new antibiotics in the face of growing bacterial resistance, says a policy expert with the Infectious Diseases Society of America (IDSA).

May 09, 2012

May 09, 2012

Bathroom-stored grocery bag fingered in norovirus outbreak

(CIDRAP News) – The role of fomites in norovirus outbreaks has been difficult to pin down, but Oregon health officials today described how a reusable grocery bag left in a bathroom where a patient was sick spread the virus to members of a girls' soccer team and their chaperones.

Mar 28, 2012

Mar 28, 2012

Scientists volley ahead of more dual-use H5N1 debate

(CIDRAP News) – As researchers from both sides of the debate over two controversial H5N1 studies weighed in yesterday on full publication versus a more cautionary approach, two US journals said they are developing policies to address any future such instances.

Mar 21, 2012

Mar 21, 2012

IDSA: Antibiotics not needed for most sinus infections

(CIDRAP News) – More than 90% of sinus infections are caused by viruses and should not be treated with antibiotics, a common practice that can increase bacterial resistance to the drugs, the Infectious Diseases Society of America (IDSA) said in new guidelines released today.

Mar 15, 2012

Mar 15, 2012

Groups aim to increase antimicrobial stewardship

(CIDRAP News) – Infectious-disease specialty groups are teaming up to call for increased use of antimicrobial stewardship programs, saying such efforts can help preserve the effectiveness of anti-infective drugs while reducing medical costs.

Mar 08, 2012

Mar 08, 2012

IDSA proposes fast-track system for limited-use antibiotics

(CIDRAP News) – As part of its effort to shore up the waning supply of effective antimicrobials, the Infectious Diseases Society of America (IDSA) has proposed a streamlined approval pathway for antibiotics intended for special classes of patients who lack other treatment options.

Nov 22, 2011

Nov 22, 2011

Studies seek better assessment of risk for resistant pneumonia

(CIDRAP News) – Two new studies shed some light on risk factors for drug-resistant healthcare-associated pneumonia (HCAP), one suggesting which factors carry the most weight and the other showing that a simple clinical scoring method can help identify the patients at greatest risk.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»